Layla Zulfa

A National Imperative: Breast Cancer Canada Issues Bold Three-Pillar Mandate for Federal Budget 2025 a-national-imperative-breast-cancer-canada-issues-bold-three-pillar-mandate-for-federal-budget-2025

A National Imperative: Breast Cancer Canada Issues Bold Three-Pillar Mandate for Federal Budget 2025

Layla Zulfa May 23, 2026

OTTAWA – As the federal government prepares its upcoming budget, Breast Cancer Canada (BCC) has submitted a...

From Lab Bench to Bedside: How the Broad Institute is Redefining Modern Medicine from-lab-bench-to-bedside-how-the-broad-institute-is-redefining-modern-medicine

From Lab Bench to Bedside: How the Broad Institute is Redefining Modern Medicine

Layla Zulfa May 22, 2026

In the landscape of 21st-century biomedicine, few institutions have exerted as profound an influence on human health...

Bridging the Gap: Innovative Immune Therapies for TBI and Alzheimer’s Disease bridging-the-gap-innovative-immune-therapies-for-tbi-and-alzheimers-disease

Bridging the Gap: Innovative Immune Therapies for TBI and Alzheimer’s Disease

Layla Zulfa May 22, 2026

Traumatic brain injury (TBI) is a silent global epidemic. Every year, an estimated 69 million people sustain...

Bridging the Gap: The Launch of the BCC-CSSO Career Development Research Award and the Future of Surgical Oncology bridging-the-gap-the-launch-of-the-bcc-csso-career-development-research-award-and-the-future-of-surgical-oncology

Bridging the Gap: The Launch of the BCC-CSSO Career Development Research Award and the Future of Surgical Oncology

Layla Zulfa May 22, 2026

In a landmark move to fortify Canada’s position at the forefront of oncological innovation, Breast Cancer Canada...

Unlocking the Colorectal Cancer Paradox: MSK Researchers Uncover Dual Roles of Immune Cells, Paving Way for Targeted Therapies unlocking-the-colorectal-cancer-paradox-msk-researchers-uncover-dual-roles-of-immune-cells-paving-way-for-targeted-therapies

Unlocking the Colorectal Cancer Paradox: MSK Researchers Uncover Dual Roles of Immune Cells, Paving Way for Targeted Therapies

Layla Zulfa May 22, 2026

New York, NY – For decades, the role of regulatory T (Treg) cells in colorectal cancer has...

Sugar Coating the Holidays: Finding Meaning and Resilience During Cancer Treatment sugar-coating-the-holidays-finding-meaning-and-resilience-during-cancer-treatment

Sugar Coating the Holidays: Finding Meaning and Resilience During Cancer Treatment

Layla Zulfa May 21, 2026

By Editorial Staff September 19, 2025 The arrival of the Jewish New Year, Rosh Hashanah, is traditionally...

The Final Threshold: How a Terminal Diagnosis Bridged a Lifelong Emotional Divide the-final-threshold-how-a-terminal-diagnosis-bridged-a-lifelong-emotional-divide

The Final Threshold: How a Terminal Diagnosis Bridged a Lifelong Emotional Divide

Layla Zulfa May 20, 2026

By [Your Name/Journalistic Staff] For decades, Nancy Groves served as a professional navigator for others, working as...

Relay Therapeutics’ Zovegalisib: A Potential New Standard in Treating Rare Vascular Anomalies relay-therapeutics-zovegalisib-a-potential-new-standard-in-treating-rare-vascular-anomalies

Relay Therapeutics’ Zovegalisib: A Potential New Standard in Treating Rare Vascular Anomalies

Layla Zulfa May 20, 2026

In the high-stakes landscape of precision medicine, few targets have captured the attention of the biopharmaceutical industry...

BioMarin’s Rare Disease Aspirations Stumble: BMN 401 Fails Key Regulatory Hurdle biomarins-rare-disease-aspirations-stumble-bmn-401-fails-key-regulatory-hurdle

BioMarin’s Rare Disease Aspirations Stumble: BMN 401 Fails Key Regulatory Hurdle

Layla Zulfa May 19, 2026

By Delilah Alvarado Published May 19, 2026 BioMarin Pharmaceutical, a company long heralded for its ability to...

The Architects of Our Genetic Future: Inside the Origin Stories of the GTAC Team the-architects-of-our-genetic-future-inside-the-origin-stories-of-the-gtac-team

The Architects of Our Genetic Future: Inside the Origin Stories of the GTAC Team

Layla Zulfa May 17, 2026

The field of genomics represents one of the most significant frontiers in modern medicine. By decoding the...

A National Imperative: Breast Cancer Canada Issues Bold Three-Pillar Mandate for Federal Budget 2025

From Lab Bench to Bedside: How the Broad Institute is Redefining Modern Medicine

Bridging the Gap: Innovative Immune Therapies for TBI and Alzheimer’s Disease

Bridging the Gap: The Launch of the BCC-CSSO Career Development Research Award and the Future of Surgical Oncology

Unlocking the Colorectal Cancer Paradox: MSK Researchers Uncover Dual Roles of Immune Cells, Paving Way for Targeted Therapies

Sugar Coating the Holidays: Finding Meaning and Resilience During Cancer Treatment

The Final Threshold: How a Terminal Diagnosis Bridged a Lifelong Emotional Divide

Relay Therapeutics’ Zovegalisib: A Potential New Standard in Treating Rare Vascular Anomalies

BioMarin’s Rare Disease Aspirations Stumble: BMN 401 Fails Key Regulatory Hurdle

The Architects of Our Genetic Future: Inside the Origin Stories of the GTAC Team

You may have missed

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment